Medicamen Biotech Share Price

Name: Medicamen Biotech
Brand: Medicamen Biotech

Pharmaceuticals Small Cap

₹529.₉₅ -3.25 (-0.61%)

05 Nov, 2024 17:19

Start SIP in MEDICAMEQ

Start SIP

Performance

Low
₹527

High
₹541

52 Week Low
₹355

52 Week High
₹690

Open Price₹530
Previous Close₹533
Volume13,036

Investment Returns

Over 1 Month -7.46%
Over 3 Month + 23.94%
Over 6 Month -2.08%
Over 1 Year -18.83%

Smart Investing Starts Here Start SIP with Medicamen Biotech for Steady Growth!

Invest Now

Medicamen Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

P/E Ratio
96.5

PEG Ratio
-1.8

Market Cap Cr
674

P/B Ratio
3.3

Average True Range
34.56

EPS
10.5

Dividend Yield
0.2

MACD Signal
5.7

RSI
53.37

MFI
78.62

Standalone Consolidated

Indicator	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Net Sales/Income from operations	41.48	45.01	44.20	42.67	40.50
Total Income From Operations	41.48	45.01	44.20	42.67	40.50
P/L Before Interest, Excpt. Items & Tax	3.69	5.59	4.66	4.91	6.11
P/L Before Exceptional Items & Tax	3.02	3.73	4.01	4.00	5.15
P/L After Tax from Ordinary Activities	2.26	3.10	2.77	3.01	4.42
Net Profit/Loss For the Period	2.26	3.10	2.77	3.01	4.42

Indicator	Mar 24	Mar 23
Revenue From Operations [Gross]	170.96	137.43
Revenue From Operations [Net]	170.96	137.43
Total Operating Revenues	172.39	137.88
Total Revenue	174.69	140.35
Total Expenses	157.80	123.01
Profit/Loss Before Tax	16.89	17.33
Profit/Loss For The Period	13.30	15.00

Indicator	Mar 24	Mar 23
Net CashFlow - Operating Activity	-0.25	-3.50
Net Cash Used In Investing Activity	-8.71	-7.54
Net Cash Used in Finance Activity	3.14	27.67
Net Inc/Dec In Cash And Equivalent	-5.82	16.63
Cash And Equivalent End Of Year	14.62	20.44

Indicator	Mar 24	Mar 23
Total Share Capital	12.71	12.65
Total Non-Current Liabilities	2.71	2.53
Total Current Liabilities	82.30	80.46
Total Capital And Liabilities	294.21	276.78
Total Non-Current Assets	141.84	118.81
Total Current Assets	152.37	157.97
Total Assets	294.21	276.78

Indicator	2024	2023
EBIT Margin (%)	12.33	14.69
Return On Capital Employed (%)	10.03	10.31
Return On Equity (%)	6.35	7.78
Long Term Debt To Equity (%)	0.45	0.45
Book Value/Share (INR)	164.54	152.30

Indicator	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Net Sales/Income from operations	43.05	47.32	46.50	43.54	41.94
Total Income From Operations	43.05	47.32	46.50	43.54	41.94
P/L Before Interest, Excpt. Items & Tax	2.26	4.54	3.92	3.37	5.64
P/L Before Exceptional Items & Tax	1.56	2.66	3.27	2.46	4.68
P/L After Tax from Ordinary Activities	0.80	2.04	2.03	1.48	3.95
Net Profit/Loss For the Period	0.80	2.04	2.03	1.48	3.95

Indicator	Mar 24	Mar 23
Revenue From Operations [Gross]	177.88	140.41
Revenue From Operations [Net]	177.88	140.41
Total Operating Revenues	179.31	140.87
Total Revenue	181.63	143.33
Total Expenses	168.56	126.28
Profit/Loss Before Tax	13.08	17.05
Profit/Loss For The Period	9.49	14.73

Indicator	Mar 24	Mar 23
Net CashFlow - Operating Activity	-6.74	-6.29
Net Cash Used In Investing Activity	-5.56	-5.88
Net Cash Used in Finance Activity	6.31	29.13
Net Inc/Dec In Cash And Equivalent	-5.99	16.95
Cash And Equivalent End Of Year	14.79	20.78

Indicator	Mar 24	Mar 23
Total Share Capital	12.71	12.65
Total Non-Current Liabilities	3.01	2.53
Total Current Liabilities	84.56	82.57
Total Capital And Liabilities	294.55	278.52
Total Non-Current Assets	134.96	115.15
Total Current Assets	159.59	163.36
Total Assets	294.55	278.52

Indicator	2024	2023
EBIT Margin (%)	9.74	14.17
Return On Capital Employed (%)	8.32	10.19
Return On Equity (%)	5.28	7.77
Long Term Debt To Equity (%)	0.60	0.45
Book Value/Share (INR)	162.79	150.82

Medicamen Biotech Technicals

EMA & SMA

Current Price

₹529.₉₅

-3.25 (-0.61%)

Bullish Moving Average 13

Bearish Moving Average 3

EMA SMA

20 Day
₹521.84

50 Day
₹502.69

100 Day
₹489.35

200 Day
₹505.65

Resistance and Support

535.22

R3 572.38
R2 560.67
R1 546.93

S1 521.48
S2 509.77
S3 496.03

Is Medicamen Biotech Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Medicamen Biotech Ltd specializes in the manufacturing and marketing of pharmaceutical formulations, including injectables, tablets, and syrups. The company serves domestic and international markets, focusing on quality, innovation, and regulatory compliance in the healthcare sector. Medicamen Biotech has an operating revenue of Rs. 180.41 Cr. on a trailing 12-month basis. An annual revenue growth of 27% is outstanding, Pre-tax margin of 7% is okay, ROE of 5% is fair but needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 9% and 12% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 11% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 20 which is a POOR score indicating inconsistency in earnings, a RS Rating of 47 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 32 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Medicamen Biotech Corporate Actions - Bonus, Splits, Dividends

Board

Date	Purpose	Remarks
2024-08-13	Quarterly Results
2024-05-29	Audited Results & Final Dividend
2024-02-12	Quarterly Results
2023-11-10	Quarterly Results
2023-08-08	Quarterly Results

Medicamen Biotech F&O

Medicamen Biotech Shareholding Pattern

Sep 24
Jun 24
Mar 24
Dec 23

Promoters
Mutual Funds
Foreign Portfolio Investors
Individual Investors
Others

Promoters

42.99%

Mutual Funds

Foreign Portfolio Investors

0.06%

Individual Investors

32.44%

Others

24.51%

NSE Symbol
MEDICAMEQ

BSE Symbol
531146

ISIN
INE646B01010

Start Investing in 5* minutes

+91

By proceeding, you agree to our T&Cs*

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

Medicamen Biotech Share Price

₹529.₉₅ -3.25 (-0.61%)

Performance

Investment Returns

Smart Investing Starts Here Start SIP with Medicamen Biotech for Steady Growth!

Medicamen Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Medicamen Biotech Financial

Medicamen Biotech Technicals

EMA & SMA

Resistance and Support

Is Medicamen Biotech Worth Buying?

Ratings

Medicamen Biotech Corporate Actions - Bonus, Splits, Dividends

Medicamen Biotech F&O

Medicamen Biotech Shareholding Pattern

Medicamen Biotech FAQs

What is Share Price of Medicamen Biotech ?

What is the Market Cap of Medicamen Biotech ?

What is the P/E ratio of Medicamen Biotech ?

What is the PB ratio of Medicamen Biotech ?

Start Investing in 5* minutes

Medicamen Biotech Share Price

₹529.95 -3.25 (-0.61%)

Performance

Investment Returns

Smart Investing Starts Here Start SIP with Medicamen Biotech for Steady Growth!

Medicamen Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Medicamen Biotech Financial

Medicamen Biotech Technicals

EMA & SMA

Resistance and Support

Is Medicamen Biotech Worth Buying?

Ratings

Medicamen Biotech Corporate Actions - Bonus, Splits, Dividends

Medicamen Biotech F&O

Medicamen Biotech Shareholding Pattern

Medicamen Biotech FAQs

What is Share Price of Medicamen Biotech ?

What is the Market Cap of Medicamen Biotech ?

What is the P/E ratio of Medicamen Biotech ?

What is the PB ratio of Medicamen Biotech ?

Start Investing in 5* minutes

₹529.₉₅ -3.25 (-0.61%)